Catalent | Omløpsmidler

Current Assets Endring Dato
Agilent USD 4.34B 152M 2023-12
AstraZeneca USD 22.5B 338M 2023-09
Bruker USD 2.16B 135.6M 2023-12
Catalent USD 2.57B 44M 2023-12
Charles River Laboratories USD 1.61B 164.34M 2023-12
Cigna USD 34.52B 193M 2023-09
Dentsply International USD 1.97B 60M 2023-12
Eli Lilly USD 23.01B 1.68B 2023-09
Hologic USD 3.49B 690.3M 2023-12
Illumina USD 2.61B 103M 2023-12
IQVIA Holdings USD 5.6B 388M 2023-12
Lonza CHF 5.62B 92M 2023-06
McKesson USD 47.53B 1.99B 2023-09
Mettler Toledo International USD 1.23B 33.29M 2023-12
Pfizer USD 74.01B 665M 2023-09
Repligen USD 978.46M 20.13M 2023-09
Revvity USD 3B 87.85M 2023-12
Roche Holding CHF 30.98B 2.84B 2023-06
Supernus Pharmaceuticals USD 493.11M 43.75M 2023-12
Waters USD 1.63B 46.66M 2023-09



Catalent Omløpsmidler - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2024.